A recent study presented results from a randomized controlled trial (ClinicalTrials.gov identifier: NCT01681602; see Table 4) evaluating changes in the neuroprotective proteins proBDNF, BDNF, and humanin in plasma neuron-derived EVs from patients with mild-to-moderate AD [126]. Here, BDNF is linked to Alzheimer disease.